Table of Content

1 Report Overview
1.1 Gabapentin Drug Definition
1.2 Market by Type
1.2.1 Global Gabapentin Drug Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 Capsule
1.2.3 Tablet
1.2.4 Oral Solution
1.3 Market Segment by Application
1.3.1 Global Gabapentin Drug Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Postherpetic Neuralgia in Adults
1.3.3 Partial Onset Seizures
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Gabapentin Drug Sales
2.1 Global Gabapentin Drug Revenue Estimates and Forecasts 2018-2034
2.2 Global Gabapentin Drug Revenue by Region: 2018 VS 2024 VS 2034
2.3 Global Gabapentin Drug Revenue by Region
2.3.1 Global Gabapentin Drug Revenue by Region (2018-2023)
2.3.2 Global Gabapentin Drug Revenue by Region (2024-2034)
2.4 Global Gabapentin Drug Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Gabapentin Drug Sales Quantity by Region: 2018 VS 2024 VS 2034
2.6 Global Gabapentin Drug Sales Quantity by Region
2.6.1 Global Gabapentin Drug Sales Quantity by Region (2018-2023)
2.6.2 Global Gabapentin Drug Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Gabapentin Drug Sales Quantity by Manufacturers
3.1.1 Global Gabapentin Drug Sales Quantity by Manufacturers (2018-2023)
3.1.2 Global Gabapentin Drug Sales Quantity Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Companies by Gabapentin Drug Sales in 2024
3.2 Global Gabapentin Drug Revenue by Manufacturers
3.2.1 Global Gabapentin Drug Revenue by Manufacturers (2018-2023)
3.2.2 Global Gabapentin Drug Revenue Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Gabapentin Drug Revenue in 2024
3.3 Global Gabapentin Drug Sales Price by Manufacturers
3.4 Global Key Players of Gabapentin Drug, Industry Ranking, 2021 VS 2024
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Gabapentin Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Gabapentin Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Gabapentin Drug, Product Offered and Application
3.8 Global Key Manufacturers of Gabapentin Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Gabapentin Drug Sales Quantity by Type
4.1.1 Global Gabapentin Drug Historical Sales Quantity by Type (2018-2023)
4.1.2 Global Gabapentin Drug Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Gabapentin Drug Sales Quantity Market Share by Type (2018-2034)
4.2 Global Gabapentin Drug Revenue by Type
4.2.1 Global Gabapentin Drug Historical Revenue by Type (2018-2023)
4.2.2 Global Gabapentin Drug Forecasted Revenue by Type (2024-2034)
4.2.3 Global Gabapentin Drug Revenue Market Share by Type (2018-2034)
4.3 Global Gabapentin Drug Price by Type
4.3.1 Global Gabapentin Drug Price by Type (2018-2023)
4.3.2 Global Gabapentin Drug Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Gabapentin Drug Sales Quantity by Application
5.1.1 Global Gabapentin Drug Historical Sales Quantity by Application (2018-2023)
5.1.2 Global Gabapentin Drug Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Gabapentin Drug Sales Quantity Market Share by Application (2018-2034)
5.2 Global Gabapentin Drug Revenue by Application
5.2.1 Global Gabapentin Drug Historical Revenue by Application (2018-2023)
5.2.2 Global Gabapentin Drug Forecasted Revenue by Application (2024-2034)
5.2.3 Global Gabapentin Drug Revenue Market Share by Application (2018-2034)
5.3 Global Gabapentin Drug Price by Application
5.3.1 Global Gabapentin Drug Price by Application (2018-2023)
5.3.2 Global Gabapentin Drug Price Forecast by Application (2024-2034)
6 North America
6.1 North America Gabapentin Drug Sales by Company
6.1.1 North America Gabapentin Drug Revenue by Company (2018-2023)
6.1.2 North America Gabapentin Drug Sales Quantity by Company (2018-2023)
6.2 North America Gabapentin Drug Market Size by Type
6.2.1 North America Gabapentin Drug Sales Quantity by Type (2018-2034)
6.2.2 North America Gabapentin Drug Revenue by Type (2018-2034)
6.3 North America Gabapentin Drug Market Size by Application
6.3.1 North America Gabapentin Drug Sales Quantity by Application (2018-2034)
6.3.2 North America Gabapentin Drug Revenue by Application (2018-2034)
6.4 North America Gabapentin Drug Market Size by Country
6.4.1 North America Gabapentin Drug Revenue by Country: 2018 VS 2024 VS 2034
6.4.2 North America Gabapentin Drug Revenue by Country (2018-2034)
6.4.3 North America Gabapentin Drug Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Gabapentin Drug Sales by Company
7.1.1 Europe Gabapentin Drug Sales Quantity by Company (2018-2023)
7.1.2 Europe Gabapentin Drug Revenue by Company (2018-2023)
7.2 Europe Gabapentin Drug Market Size by Type
7.2.1 Europe Gabapentin Drug Sales Quantity by Type (2018-2034)
7.2.2 Europe Gabapentin Drug Revenue by Type (2018-2034)
7.3 Europe Gabapentin Drug Market Size by Application
7.3.1 Europe Gabapentin Drug Sales Quantity by Application (2018-2034)
7.3.2 Europe Gabapentin Drug Revenue by Application (2018-2034)
7.4 Europe Gabapentin Drug Market Size by Country
7.4.1 Europe Gabapentin Drug Revenue by Country: 2018 VS 2024 VS 2034
7.4.2 Europe Gabapentin Drug Revenue by Country (2018-2034)
7.4.3 Europe Gabapentin Drug Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Gabapentin Drug Sales by Company
8.1.1 China Gabapentin Drug Sales Quantity by Company (2018-2023)
8.1.2 China Gabapentin Drug Revenue by Company (2018-2023)
8.2 China Gabapentin Drug Market Size by Type
8.2.1 China Gabapentin Drug Sales Quantity by Type (2018-2034)
8.2.2 China Gabapentin Drug Revenue by Type (2018-2034)
8.3 China Gabapentin Drug Market Size by Application
8.3.1 China Gabapentin Drug Sales Quantity by Application (2018-2034)
8.3.2 China Gabapentin Drug Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Gabapentin Drug Sales by Company
9.1.1 APAC Gabapentin Drug Sales Quantity by Company (2018-2023)
9.1.2 APAC Gabapentin Drug Revenue by Company (2018-2023)
9.2 APAC Gabapentin Drug Market Size by Type
9.2.1 APAC Gabapentin Drug Sales Quantity by Type (2018-2034)
9.2.2 APAC Gabapentin Drug Revenue by Type (2018-2034)
9.3 APAC Gabapentin Drug Market Size by Application
9.3.1 APAC Gabapentin Drug Sales Quantity by Application (2018-2034)
9.3.2 APAC Gabapentin Drug Revenue by Application (2018-2034)
9.4 APAC Gabapentin Drug Market Size by Region
9.4.1 APAC Gabapentin Drug Revenue by Region: 2018 VS 2024 VS 2034
9.4.2 APAC Gabapentin Drug Revenue by Region (2018-2034)
9.4.3 APAC Gabapentin Drug Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Gabapentin Drug Sales by Company
10.1.1 Middle East, Africa and Latin America Gabapentin Drug Sales Quantity by Company (2018-2023)
10.1.2 Middle East, Africa and Latin America Gabapentin Drug Revenue by Company (2018-2023)
10.2 Middle East, Africa and Latin America Gabapentin Drug Market Size by Type
10.2.1 Middle East, Africa and Latin America Gabapentin Drug Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Gabapentin Drug Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Gabapentin Drug Market Size by Application
10.3.1 Middle East, Africa and Latin America Gabapentin Drug Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Gabapentin Drug Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Gabapentin Drug Market Size by Country
10.4.1 Middle East, Africa and Latin America Gabapentin Drug Revenue by Country: 2018 VS 2024 VS 2034
10.4.2 Middle East, Africa and Latin America Gabapentin Drug Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Gabapentin Drug Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Gabapentin Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.1.4 Pfizer Gabapentin Drug Products and Services
11.1.5 Pfizer Gabapentin Drug SWOT Analysis
11.1.6 Pfizer Recent Developments
11.2 Depomed
11.2.1 Depomed Company Information
11.2.2 Depomed Overview
11.2.3 Depomed Gabapentin Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.2.4 Depomed Gabapentin Drug Products and Services
11.2.5 Depomed Gabapentin Drug SWOT Analysis
11.2.6 Depomed Recent Developments
11.3 Apotex
11.3.1 Apotex Company Information
11.3.2 Apotex Overview
11.3.3 Apotex Gabapentin Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.3.4 Apotex Gabapentin Drug Products and Services
11.3.5 Apotex Gabapentin Drug SWOT Analysis
11.3.6 Apotex Recent Developments
11.4 Teva
11.4.1 Teva Company Information
11.4.2 Teva Overview
11.4.3 Teva Gabapentin Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.4.4 Teva Gabapentin Drug Products and Services
11.4.5 Teva Gabapentin Drug SWOT Analysis
11.4.6 Teva Recent Developments
11.5 Acella Pharmaceuticals
11.5.1 Acella Pharmaceuticals Company Information
11.5.2 Acella Pharmaceuticals Overview
11.5.3 Acella Pharmaceuticals Gabapentin Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.5.4 Acella Pharmaceuticals Gabapentin Drug Products and Services
11.5.5 Acella Pharmaceuticals Gabapentin Drug SWOT Analysis
11.5.6 Acella Pharmaceuticals Recent Developments
11.6 Taro
11.6.1 Taro Company Information
11.6.2 Taro Overview
11.6.3 Taro Gabapentin Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.6.4 Taro Gabapentin Drug Products and Services
11.6.5 Taro Gabapentin Drug SWOT Analysis
11.6.6 Taro Recent Developments
11.7 Sun Pharmaceutical
11.7.1 Sun Pharmaceutical Company Information
11.7.2 Sun Pharmaceutical Overview
11.7.3 Sun Pharmaceutical Gabapentin Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.7.4 Sun Pharmaceutical Gabapentin Drug Products and Services
11.7.5 Sun Pharmaceutical Gabapentin Drug SWOT Analysis
11.7.6 Sun Pharmaceutical Recent Developments
11.8 Glenmark
11.8.1 Glenmark Company Information
11.8.2 Glenmark Overview
11.8.3 Glenmark Gabapentin Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.8.4 Glenmark Gabapentin Drug Products and Services
11.8.5 Glenmark Gabapentin Drug SWOT Analysis
11.8.6 Glenmark Recent Developments
11.9 Amneal Pharmaceuticals
11.9.1 Amneal Pharmaceuticals Company Information
11.9.2 Amneal Pharmaceuticals Overview
11.9.3 Amneal Pharmaceuticals Gabapentin Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.9.4 Amneal Pharmaceuticals Gabapentin Drug Products and Services
11.9.5 Amneal Pharmaceuticals Gabapentin Drug SWOT Analysis
11.9.6 Amneal Pharmaceuticals Recent Developments
11.10 Aurobindo Pharma
11.10.1 Aurobindo Pharma Company Information
11.10.2 Aurobindo Pharma Overview
11.10.3 Aurobindo Pharma Gabapentin Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.10.4 Aurobindo Pharma Gabapentin Drug Products and Services
11.10.5 Aurobindo Pharma Gabapentin Drug SWOT Analysis
11.10.6 Aurobindo Pharma Recent Developments
11.11 Zydus Pharmaceuticals
11.11.1 Zydus Pharmaceuticals Company Information
11.11.2 Zydus Pharmaceuticals Overview
11.11.3 Zydus Pharmaceuticals Gabapentin Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.11.4 Zydus Pharmaceuticals Gabapentin Drug Products and Services
11.11.5 Zydus Pharmaceuticals Recent Developments
11.12 Hi-Tech Pharmaceuticals
11.12.1 Hi-Tech Pharmaceuticals Company Information
11.12.2 Hi-Tech Pharmaceuticals Overview
11.12.3 Hi-Tech Pharmaceuticals Gabapentin Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.12.4 Hi-Tech Pharmaceuticals Gabapentin Drug Products and Services
11.12.5 Hi-Tech Pharmaceuticals Recent Developments
11.13 Marksans Pharma
11.13.1 Marksans Pharma Company Information
11.13.2 Marksans Pharma Overview
11.13.3 Marksans Pharma Gabapentin Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.13.4 Marksans Pharma Gabapentin Drug Products and Services
11.13.5 Marksans Pharma Recent Developments
11.14 Mylan
11.14.1 Mylan Company Information
11.14.2 Mylan Overview
11.14.3 Mylan Gabapentin Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.14.4 Mylan Gabapentin Drug Products and Services
11.14.5 Mylan Recent Developments
11.15 InvaGen Pharmaceuticals
11.15.1 InvaGen Pharmaceuticals Company Information
11.15.2 InvaGen Pharmaceuticals Overview
11.15.3 InvaGen Pharmaceuticals Gabapentin Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.15.4 InvaGen Pharmaceuticals Gabapentin Drug Products and Services
11.15.5 InvaGen Pharmaceuticals Recent Developments
11.16 Alkem Laboratories
11.16.1 Alkem Laboratories Company Information
11.16.2 Alkem Laboratories Overview
11.16.3 Alkem Laboratories Gabapentin Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.16.4 Alkem Laboratories Gabapentin Drug Products and Services
11.16.5 Alkem Laboratories Recent Developments
11.17 Tris Pharma
11.17.1 Tris Pharma Company Information
11.17.2 Tris Pharma Overview
11.17.3 Tris Pharma Gabapentin Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.17.4 Tris Pharma Gabapentin Drug Products and Services
11.17.5 Tris Pharma Recent Developments
11.18 ACI HealthCare Limited
11.18.1 ACI HealthCare Limited Company Information
11.18.2 ACI HealthCare Limited Overview
11.18.3 ACI HealthCare Limited Gabapentin Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.18.4 ACI HealthCare Limited Gabapentin Drug Products and Services
11.18.5 ACI HealthCare Limited Recent Developments
11.19 Jiangsu Hengrui Medicine
11.19.1 Jiangsu Hengrui Medicine Company Information
11.19.2 Jiangsu Hengrui Medicine Overview
11.19.3 Jiangsu Hengrui Medicine Gabapentin Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.19.4 Jiangsu Hengrui Medicine Gabapentin Drug Products and Services
11.19.5 Jiangsu Hengrui Medicine Recent Developments
11.20 CSPC Ouyi Pharmaceutical
11.20.1 CSPC Ouyi Pharmaceutical Company Information
11.20.2 CSPC Ouyi Pharmaceutical Overview
11.20.3 CSPC Ouyi Pharmaceutical Gabapentin Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.20.4 CSPC Ouyi Pharmaceutical Gabapentin Drug Products and Services
11.20.5 CSPC Ouyi Pharmaceutical Recent Developments
11.21 Sciegen Pharmaceuticals
11.21.1 Sciegen Pharmaceuticals Company Information
11.21.2 Sciegen Pharmaceuticals Overview
11.21.3 Sciegen Pharmaceuticals Gabapentin Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.21.4 Sciegen Pharmaceuticals Gabapentin Drug Products and Services
11.21.5 Sciegen Pharmaceuticals Recent Developments
11.22 Epic Pharma
11.22.1 Epic Pharma Company Information
11.22.2 Epic Pharma Overview
11.22.3 Epic Pharma Gabapentin Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.22.4 Epic Pharma Gabapentin Drug Products and Services
11.22.5 Epic Pharma Recent Developments
11.23 Lupin Limited
11.23.1 Lupin Limited Company Information
11.23.2 Lupin Limited Overview
11.23.3 Lupin Limited Gabapentin Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.23.4 Lupin Limited Gabapentin Drug Products and Services
11.23.5 Lupin Limited Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Gabapentin Drug Value Chain Analysis
12.2 Gabapentin Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Gabapentin Drug Production Mode & Process
12.4 Gabapentin Drug Sales and Marketing
12.4.1 Gabapentin Drug Sales Channels
12.4.2 Gabapentin Drug Distributors
12.5 Gabapentin Drug Customers
13 Market Dynamics
13.1 Gabapentin Drug Industry Trends
13.2 Gabapentin Drug Market Drivers
13.3 Gabapentin Drug Market Challenges
13.4 Gabapentin Drug Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Gabapentin Drug Market Size Growth Rate (CAGR) by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Capsule
Table 3. Major Manufacturers of Tablet
Table 4. Major Manufacturers of Oral Solution
Table 5. Global Gabapentin Drug Market Size Growth Rate (CAGR) by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 6. Global Gabapentin Drug Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 7. Global Gabapentin Drug Revenue by Region (2018-2023) & (US$ Million)
Table 8. Global Gabapentin Drug Revenue Market Share by Region (2018-2023)
Table 9. Global Gabapentin Drug Revenue by Region (2024-2034) & (US$ Million)
Table 10. Global Gabapentin Drug Revenue Market Share by Region (2024-2034)
Table 11. Global Gabapentin Drug Sales Quantity by Region: 2018 VS 2024 VS 2034 (K Units)
Table 12. Global Gabapentin Drug Sales by Region (2018-2023) & (K Units)
Table 13. Global Gabapentin Drug Sales Market Share by Region (2018-2023)
Table 14. Global Gabapentin Drug Sales by Region (2024-2034) & (K Units)
Table 15. Global Gabapentin Drug Sales Market Share by Region (2024-2034)
Table 16. Global Gabapentin Drug Sales Quantity by Manufacturers (2018-2023) & (K Units)
Table 17. Global Gabapentin Drug Sales Quantity Share by Manufacturers (2018-2023)
Table 18. Global Gabapentin Drug Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 19. Global Gabapentin Drug Revenue Share by Manufacturers (2018-2023)
Table 20. Global Gabapentin Drug Price by Manufacturers 2018-2023 (USD/Unit)
Table 21. Global Key Players of Gabapentin Drug, Industry Ranking, 2021 VS 2024
Table 22. Global Gabapentin Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Gabapentin Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gabapentin Drug as of 2024)
Table 24. Global Key Manufacturers of Gabapentin Drug, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Gabapentin Drug, Product Offered and Application
Table 26. Global Key Manufacturers of Gabapentin Drug, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Gabapentin Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 29. Global Gabapentin Drug Sales Quantity by Type (2024-2034) & (K Units)
Table 30. Global Gabapentin Drug Sales Quantity Share by Type (2018-2023)
Table 31. Global Gabapentin Drug Sales Quantity Share by Type (2024-2034)
Table 32. Global Gabapentin Drug Revenue by Type (2018-2023) & (US$ Million)
Table 33. Global Gabapentin Drug Revenue by Type (2024-2034) & (US$ Million)
Table 34. Global Gabapentin Drug Revenue Share by Type (2018-2023)
Table 35. Global Gabapentin Drug Revenue Share by Type (2024-2034)
Table 36. Gabapentin Drug Price by Type (2018-2023) & (USD/Unit)
Table 37. Global Gabapentin Drug Price Forecast by Type (2024-2034) & (USD/Unit)
Table 38. Global Gabapentin Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 39. Global Gabapentin Drug Sales Quantity by Application (2024-2034) & (K Units)
Table 40. Global Gabapentin Drug Sales Quantity Share by Application (2018-2023)
Table 41. Global Gabapentin Drug Sales Quantity Share by Application (2024-2034)
Table 42. Global Gabapentin Drug Revenue by Application (2018-2023) & (US$ Million)
Table 43. Global Gabapentin Drug Revenue by Application (2024-2034) & (US$ Million)
Table 44. Global Gabapentin Drug Revenue Share by Application (2018-2023)
Table 45. Global Gabapentin Drug Revenue Share by Application (2024-2034)
Table 46. Gabapentin Drug Price by Application (2018-2023) & (USD/Unit)
Table 47. Global Gabapentin Drug Price Forecast by Application (2024-2034) & (USD/Unit)
Table 48. North America Gabapentin Drug Revenue by Company (2018-2023) & (US$ Million)
Table 49. North America Gabapentin Drug Sales Quantity by Company (2018-2023) & (K Units)
Table 50. North America Gabapentin Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 51. North America Gabapentin Drug Sales Quantity by Type (2024-2034) & (K Units)
Table 52. North America Gabapentin Drug Revenue by Type (2018-2023) & (US$ Million)
Table 53. North America Gabapentin Drug Revenue by Type (2024-2034) & (US$ Million)
Table 54. North America Gabapentin Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 55. North America Gabapentin Drug Sales Quantity by Application (2024-2034) & (K Units)
Table 56. North America Gabapentin Drug Revenue by Application (2018-2023) & (US$ Million)
Table 57. North America Gabapentin Drug Revenue by Application (2024-2034) & (US$ Million)
Table 58. North America Gabapentin Drug Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 59. North America Gabapentin Drug Revenue by Country (2018-2023) & (US$ Million)
Table 60. North America Gabapentin Drug Revenue by Country (2024-2034) & (US$ Million)
Table 61. North America Gabapentin Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 62. North America Gabapentin Drug Sales Quantity by Country (2024-2034) & (K Units)
Table 63. Europe Gabapentin Drug Sales Quantity by Company (2018-2023) & (K Units)
Table 64. Europe Gabapentin Drug Revenue by Company (2018-2023) & (US$ Million)
Table 65. Europe Gabapentin Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 66. Europe Gabapentin Drug Sales Quantity by Type (2024-2034) & (K Units)
Table 67. Europe Gabapentin Drug Revenue by Type (2018-2023) & (US$ Million)
Table 68. Europe Gabapentin Drug Revenue by Type (2024-2034) & (US$ Million)
Table 69. Europe Gabapentin Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 70. Europe Gabapentin Drug Sales Quantity by Application (2024-2034) & (K Units)
Table 71. Europe Gabapentin Drug Revenue by Application (2018-2023) & (US$ Million)
Table 72. Europe Gabapentin Drug Revenue by Application (2024-2034) & (US$ Million)
Table 73. Europe Gabapentin Drug Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 74. Europe Gabapentin Drug Revenue by Country (2018-2023) & (US$ Million)
Table 75. Europe Gabapentin Drug Revenue by Country (2024-2034) & (US$ Million)
Table 76. Europe Gabapentin Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 77. Europe Gabapentin Drug Sales Quantity by Country (2024-2034) & (K Units)
Table 78. China Gabapentin Drug Sales Quantity by Company (2018-2023) & (K Units)
Table 79. China Gabapentin Drug Revenue by Company (2018-2023) & (US$ Million)
Table 80. China Gabapentin Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 81. China Gabapentin Drug Sales Quantity by Type (2024-2034) & (K Units)
Table 82. China Gabapentin Drug Revenue by Type (2018-2023) & (US$ Million)
Table 83. China Gabapentin Drug Revenue by Type (2024-2034) & (US$ Million)
Table 84. China Gabapentin Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 85. China Gabapentin Drug Sales Quantity by Application (2024-2034) & (K Units)
Table 86. China Gabapentin Drug Revenue by Application (2018-2023) & (US$ Million)
Table 87. China Gabapentin Drug Revenue by Application (2024-2034) & (US$ Million)
Table 88. APAC Gabapentin Drug Sales Quantity by Company (2018-2023) & (K Units)
Table 89. APAC Gabapentin Drug Revenue by Company (2018-2023) & (US$ Million)
Table 90. APAC Gabapentin Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 91. APAC Gabapentin Drug Sales Quantity by Type (2024-2034) & (K Units)
Table 92. APAC Gabapentin Drug Revenue by Type (2018-2023) & (US$ Million)
Table 93. APAC Gabapentin Drug Revenue by Type (2024-2034) & (US$ Million)
Table 94. APAC Gabapentin Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 95. APAC Gabapentin Drug Sales Quantity by Application (2024-2034) & (K Units)
Table 96. APAC Gabapentin Drug Revenue by Application (2018-2023) & (US$ Million)
Table 97. APAC Gabapentin Drug Revenue by Application (2024-2034) & (US$ Million)
Table 98. APAC Gabapentin Drug Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 99. APAC Gabapentin Drug Revenue by Region (2018-2023) & (US$ Million)
Table 100. APAC Gabapentin Drug Revenue by Region (2024-2034) & (US$ Million)
Table 101. APAC Gabapentin Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 102. APAC Gabapentin Drug Sales Quantity by Region (2024-2034) & (K Units)
Table 103. Middle East, Africa and Latin America Gabapentin Drug Sales Quantity by Company (2018-2023) & (K Units)
Table 104. Middle East, Africa and Latin America Gabapentin Drug Revenue by Company (2018-2023) & (US$ Million)
Table 105. Middle East, Africa and Latin America Gabapentin Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 106. Middle East, Africa and Latin America Gabapentin Drug Sales Quantity by Type (2024-2034) & (K Units)
Table 107. Middle East, Africa and Latin America Gabapentin Drug Revenue by Type (2018-2023) & (US$ Million)
Table 108. Middle East, Africa and Latin America Gabapentin Drug Revenue by Type (2024-2034) & (US$ Million)
Table 109. Middle East, Africa and Latin America Gabapentin Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 110. Middle East, Africa and Latin America Gabapentin Drug Sales Quantity by Application (2024-2034) & (K Units)
Table 111. Middle East, Africa and Latin America Gabapentin Drug Revenue by Application (2018-2023) & (US$ Million)
Table 112. Middle East, Africa and Latin America Gabapentin Drug Revenue by Application (2024-2034) & (US$ Million)
Table 113. Middle East, Africa and Latin America Gabapentin Drug Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 114. Middle East, Africa and Latin America Gabapentin Drug Revenue by Country (2018-2023) & (US$ Million)
Table 115. Middle East, Africa and Latin America Gabapentin Drug Revenue by Country (2024-2034) & (US$ Million)
Table 116. Middle East, Africa and Latin America Gabapentin Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 117. Middle East, Africa and Latin America Gabapentin Drug Sales Quantity by Country (2024-2034) & (K Units)
Table 118. Pfizer Company Information
Table 119. Pfizer Description and Overview
Table 120. Pfizer Gabapentin Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 121. Pfizer Gabapentin Drug Product and Services
Table 122. Pfizer Gabapentin Drug SWOT Analysis
Table 123. Pfizer Recent Developments
Table 124. Depomed Company Information
Table 125. Depomed Description and Overview
Table 126. Depomed Gabapentin Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 127. Depomed Gabapentin Drug Product and Services
Table 128. Depomed Gabapentin Drug SWOT Analysis
Table 129. Depomed Recent Developments
Table 130. Apotex Company Information
Table 131. Apotex Description and Overview
Table 132. Apotex Gabapentin Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 133. Apotex Gabapentin Drug Product and Services
Table 134. Apotex Gabapentin Drug SWOT Analysis
Table 135. Apotex Recent Developments
Table 136. Teva Company Information
Table 137. Teva Description and Overview
Table 138. Teva Gabapentin Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 139. Teva Gabapentin Drug Product and Services
Table 140. Teva Gabapentin Drug SWOT Analysis
Table 141. Teva Recent Developments
Table 142. Acella Pharmaceuticals Company Information
Table 143. Acella Pharmaceuticals Description and Overview
Table 144. Acella Pharmaceuticals Gabapentin Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 145. Acella Pharmaceuticals Gabapentin Drug Product and Services
Table 146. Acella Pharmaceuticals Gabapentin Drug SWOT Analysis
Table 147. Acella Pharmaceuticals Recent Developments
Table 148. Taro Company Information
Table 149. Taro Description and Overview
Table 150. Taro Gabapentin Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 151. Taro Gabapentin Drug Product and Services
Table 152. Taro Gabapentin Drug SWOT Analysis
Table 153. Taro Recent Developments
Table 154. Sun Pharmaceutical Company Information
Table 155. Sun Pharmaceutical Description and Overview
Table 156. Sun Pharmaceutical Gabapentin Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 157. Sun Pharmaceutical Gabapentin Drug Product and Services
Table 158. Sun Pharmaceutical Gabapentin Drug SWOT Analysis
Table 159. Sun Pharmaceutical Recent Developments
Table 160. Glenmark Company Information
Table 161. Glenmark Description and Overview
Table 162. Glenmark Gabapentin Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 163. Glenmark Gabapentin Drug Product and Services
Table 164. Glenmark Gabapentin Drug SWOT Analysis
Table 165. Glenmark Recent Developments
Table 166. Amneal Pharmaceuticals Company Information
Table 167. Amneal Pharmaceuticals Description and Overview
Table 168. Amneal Pharmaceuticals Gabapentin Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 169. Amneal Pharmaceuticals Gabapentin Drug Product and Services
Table 170. Amneal Pharmaceuticals Gabapentin Drug SWOT Analysis
Table 171. Amneal Pharmaceuticals Recent Developments
Table 172. Aurobindo Pharma Company Information
Table 173. Aurobindo Pharma Description and Overview
Table 174. Aurobindo Pharma Gabapentin Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 175. Aurobindo Pharma Gabapentin Drug Product and Services
Table 176. Aurobindo Pharma Gabapentin Drug SWOT Analysis
Table 177. Aurobindo Pharma Recent Developments
Table 178. Zydus Pharmaceuticals Company Information
Table 179. Zydus Pharmaceuticals Description and Overview
Table 180. Zydus Pharmaceuticals Gabapentin Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 181. Zydus Pharmaceuticals Gabapentin Drug Product and Services
Table 182. Zydus Pharmaceuticals Recent Developments
Table 183. Hi-Tech Pharmaceuticals Company Information
Table 184. Hi-Tech Pharmaceuticals Description and Overview
Table 185. Hi-Tech Pharmaceuticals Gabapentin Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 186. Hi-Tech Pharmaceuticals Gabapentin Drug Product and Services
Table 187. Hi-Tech Pharmaceuticals Recent Developments
Table 188. Marksans Pharma Company Information
Table 189. Marksans Pharma Description and Overview
Table 190. Marksans Pharma Gabapentin Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 191. Marksans Pharma Gabapentin Drug Product and Services
Table 192. Marksans Pharma Recent Developments
Table 193. Mylan Company Information
Table 194. Mylan Description and Overview
Table 195. Mylan Gabapentin Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 196. Mylan Gabapentin Drug Product and Services
Table 197. Mylan Recent Developments
Table 198. InvaGen Pharmaceuticals Company Information
Table 199. InvaGen Pharmaceuticals Description and Overview
Table 200. InvaGen Pharmaceuticals Gabapentin Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 201. InvaGen Pharmaceuticals Gabapentin Drug Product and Services
Table 202. InvaGen Pharmaceuticals Recent Developments
Table 203. Alkem Laboratories Company Information
Table 204. Alkem Laboratories Description and Overview
Table 205. Alkem Laboratories Gabapentin Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 206. Alkem Laboratories Gabapentin Drug Product and Services
Table 207. Alkem Laboratories Recent Developments
Table 208. Tris Pharma Company Information
Table 209. Tris Pharma Description and Overview
Table 210. Tris Pharma Gabapentin Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 211. Tris Pharma Gabapentin Drug Product and Services
Table 212. Tris Pharma Recent Developments
Table 213. ACI HealthCare Limited Company Information
Table 214. ACI HealthCare Limited Description and Overview
Table 215. ACI HealthCare Limited Gabapentin Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 216. ACI HealthCare Limited Gabapentin Drug Product and Services
Table 217. ACI HealthCare Limited Recent Developments
Table 218. Jiangsu Hengrui Medicine Company Information
Table 219. Jiangsu Hengrui Medicine Description and Overview
Table 220. Jiangsu Hengrui Medicine Gabapentin Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 221. Jiangsu Hengrui Medicine Gabapentin Drug Product and Services
Table 222. Jiangsu Hengrui Medicine Recent Developments
Table 223. CSPC Ouyi Pharmaceutical Company Information
Table 224. CSPC Ouyi Pharmaceutical Description and Overview
Table 225. CSPC Ouyi Pharmaceutical Gabapentin Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 226. CSPC Ouyi Pharmaceutical Gabapentin Drug Product and Services
Table 227. CSPC Ouyi Pharmaceutical Recent Developments
Table 228. Sciegen Pharmaceuticals Company Information
Table 229. Sciegen Pharmaceuticals Description and Overview
Table 230. Sciegen Pharmaceuticals Gabapentin Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 231. Sciegen Pharmaceuticals Gabapentin Drug Product and Services
Table 232. Sciegen Pharmaceuticals Recent Developments
Table 233. Epic Pharma Company Information
Table 234. Epic Pharma Description and Overview
Table 235. Epic Pharma Gabapentin Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 236. Epic Pharma Gabapentin Drug Product and Services
Table 237. Epic Pharma Recent Developments
Table 238. Lupin Limited Company Information
Table 239. Lupin Limited Description and Overview
Table 240. Lupin Limited Gabapentin Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 241. Lupin Limited Gabapentin Drug Product and Services
Table 242. Lupin Limited Recent Developments
Table 243. Key Raw Materials Lists
Table 244. Raw Materials Key Suppliers Lists
Table 245. Gabapentin Drug Distributors List
Table 246. Gabapentin Drug Customers List
Table 247. Gabapentin Drug Market Trends
Table 248. Gabapentin Drug Market Drivers
Table 249. Gabapentin Drug Market Challenges
Table 250. Gabapentin Drug Market Restraints
Table 251. Research Programs/Design for This Report
Table 252. Key Data Information from Secondary Sources
Table 253. Key Data Information from Primary Sources
List of Figures
Figure 1. Gabapentin Drug Product Picture
Figure 2. Global Gabapentin Drug Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Gabapentin Drug Market Share by Type in 2024 & 2034
Figure 4. Capsule Product Picture
Figure 5. Tablet Product Picture
Figure 6. Oral Solution Product Picture
Figure 7. Global Gabapentin Drug Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 8. Global Gabapentin Drug Market Share by Application in 2024 & 2034
Figure 9. Postherpetic Neuralgia in Adults
Figure 10. Partial Onset Seizures
Figure 11. Others
Figure 12. Gabapentin Drug Report Years Considered
Figure 13. Global Gabapentin Drug Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 14. Global Gabapentin Drug Revenue 2018-2034 (US$ Million)
Figure 15. Global Gabapentin Drug Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 16. Global Gabapentin Drug Sales Quantity 2018-2034 (K Units)
Figure 17. Global Gabapentin Drug Sales Quantity Market Share by Region (2018-2023)
Figure 18. Global Gabapentin Drug Sales Quantity Market Share by Region (2024-2034)
Figure 19. North America Gabapentin Drug Sales Quantity YoY (2018-2034) & (K Units)
Figure 20. North America Gabapentin Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 21. Europe Gabapentin Drug Sales Quantity YoY (2018-2034) & (K Units)
Figure 22. Europe Gabapentin Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 23. China Gabapentin Drug Sales Quantity YoY (2018-2034) & (K Units)
Figure 24. China Gabapentin Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 25. APAC Gabapentin Drug Sales Quantity YoY (2018-2034) & (K Units)
Figure 26. APAC Gabapentin Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Gabapentin Drug Sales Quantity YoY (2018-2034) & (K Units)
Figure 28. Middle East, Africa and Latin America Gabapentin Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 29. The Top 10 and Top 5 Players Market Share by Gabapentin Drug Sales Quantity in 2024
Figure 30. The Top 10 and Top 5 Players Market Share by Gabapentin Drug Revenue in 2024
Figure 31. Gabapentin Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 32. Global Gabapentin Drug Sales Quantity Market Share by Type (2018-2034)
Figure 33. Global Gabapentin Drug Revenue Market Share by Type (2018-2034)
Figure 34. Global Gabapentin Drug Sales Quantity Market Share by Application (2018-2034)
Figure 35. Global Gabapentin Drug Revenue Market Share by Application (2018-2034)
Figure 36. North America Gabapentin Drug Revenue Market Share by Company in 2024
Figure 37. North America Gabapentin Drug Sales Quantity Market Share by Company in 2024
Figure 38. North America Gabapentin Drug Sales Quantity Market Share by Type (2018-2034)
Figure 39. North America Gabapentin Drug Revenue Market Share by Type (2018-2034)
Figure 40. North America Gabapentin Drug Sales Quantity Market Share by Application (2018-2034)
Figure 41. North America Gabapentin Drug Revenue Market Share by Application (2018-2034)
Figure 42. North America Gabapentin Drug Revenue Share by Country (2018-2034)
Figure 43. North America Gabapentin Drug Sales Quantity Share by Country (2018-2034)
Figure 44. U.S. Gabapentin Drug Revenue (2018-2034) & (US$ Million)
Figure 45. Canada Gabapentin Drug Revenue (2018-2034) & (US$ Million)
Figure 46. Europe Gabapentin Drug Sales Quantity Market Share by Company in 2024
Figure 47. Europe Gabapentin Drug Revenue Market Share by Company in 2024
Figure 48. Europe Gabapentin Drug Sales Quantity Market Share by Type (2018-2034)
Figure 49. Europe Gabapentin Drug Revenue Market Share by Type (2018-2034)
Figure 50. Europe Gabapentin Drug Sales Quantity Market Share by Application (2018-2034)
Figure 51. Europe Gabapentin Drug Revenue Market Share by Application (2018-2034)
Figure 52. Europe Gabapentin Drug Revenue Share by Country (2018-2034)
Figure 53. Europe Gabapentin Drug Sales Quantity Share by Country (2018-2034)
Figure 54. Germany Gabapentin Drug Revenue (2018-2034) & (US$ Million)
Figure 55. France Gabapentin Drug Revenue (2018-2034) & (US$ Million)
Figure 56. U.K. Gabapentin Drug Revenue (2018-2034) & (US$ Million)
Figure 57. Italy Gabapentin Drug Revenue (2018-2034) & (US$ Million)
Figure 58. Russia Gabapentin Drug Revenue (2018-2034) & (US$ Million)
Figure 59. China Gabapentin Drug Sales Quantity Market Share by Company in 2024
Figure 60. China Gabapentin Drug Revenue Market Share by Company in 2024
Figure 61. China Gabapentin Drug Sales Quantity Market Share by Type (2018-2034)
Figure 62. China Gabapentin Drug Revenue Market Share by Type (2018-2034)
Figure 63. China Gabapentin Drug Sales Quantity Market Share by Application (2018-2034)
Figure 64. China Gabapentin Drug Revenue Market Share by Application (2018-2034)
Figure 65. APAC Gabapentin Drug Sales Quantity Market Share by Company in 2024
Figure 66. APAC Gabapentin Drug Revenue Market Share by Company in 2024
Figure 67. APAC Gabapentin Drug Sales Quantity Market Share by Type (2018-2034)
Figure 68. APAC Gabapentin Drug Revenue Market Share by Type (2018-2034)
Figure 69. APAC Gabapentin Drug Sales Quantity Market Share by Application (2018-2034)
Figure 70. APAC Gabapentin Drug Revenue Market Share by Application (2018-2034)
Figure 71. APAC Gabapentin Drug Revenue Share by Region (2018-2034)
Figure 72. APAC Gabapentin Drug Sales Quantity Share by Region (2018-2034)
Figure 73. Japan Gabapentin Drug Revenue (2018-2034) & (US$ Million)
Figure 74. South Korea Gabapentin Drug Revenue (2018-2034) & (US$ Million)
Figure 75. China Taiwan Gabapentin Drug Revenue (2018-2034) & (US$ Million)
Figure 76. Southeast Asia Gabapentin Drug Revenue (2018-2034) & (US$ Million)
Figure 77. India Gabapentin Drug Revenue (2018-2034) & (US$ Million)
Figure 78. Middle East, Africa and Latin America Gabapentin Drug Sales Quantity Market Share by Company in 2024
Figure 79. Middle East, Africa and Latin America Gabapentin Drug Revenue Market Share by Company in 2024
Figure 80. Middle East, Africa and Latin America Gabapentin Drug Sales Quantity Market Share by Type (2018-2034)
Figure 81. Middle East, Africa and Latin America Gabapentin Drug Revenue Market Share by Type (2018-2034)
Figure 82. Middle East, Africa and Latin America Gabapentin Drug Sales Quantity Market Share by Application (2018-2034)
Figure 83. Middle East, Africa and Latin America Gabapentin Drug Revenue Market Share by Application (2018-2034)
Figure 84. Middle East, Africa and Latin America Gabapentin Drug Sales Quantity Share by Country (2018-2034)
Figure 85. Middle East, Africa and Latin America Gabapentin Drug Revenue Share by Country (2018-2034)
Figure 86. Brazil Gabapentin Drug Revenue (2018-2034) & (US$ Million)
Figure 87. Mexico Gabapentin Drug Revenue (2018-2034) & (US$ Million)
Figure 88. Turkey Gabapentin Drug Revenue (2018-2034) & (US$ Million)
Figure 89. Israel Gabapentin Drug Revenue (2018-2034) & (US$ Million)
Figure 90. GCC Countries Gabapentin Drug Revenue (2018-2034) & (US$ Million)
Figure 91. Gabapentin Drug Value Chain
Figure 92. Gabapentin Drug Production Process
Figure 93. Channels of Distribution (Direct Vs Distribution)
Figure 94. Distributors Profiles
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed